4processed
Form 4 — Insider Transaction
Avalo Therapeutics, Inc.(AVTX)
Filing Date
May 28, 2026
Accepted
May 28, 2026
Accession No.
0001918845-26-000016
CIK
0001534120
Insider Transactions
| Insider | Title | Type | Shares | Price | Value | Owned After | Security | Date |
|---|---|---|---|---|---|---|---|---|
| Doyle Mittie | Chief Medical Officer | Other | 679 | $8.04 | — | 47.8K | Common Stock | May 28, 2026 |
| Doyle Mittie | Chief Medical Officer | Other | 679 | $16 | — | 47.1K | Common Stock | May 28, 2026 |
| Doyle Mittie | Chief Medical Officer | Other | 679 | $0 | — | 118.3K | Stock Option (Right to Buy) | May 28, 2026 |